Skip to content
  • Sunday, 26 July 2026
  • 1:48 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Parkinson’s Disease Research Reaches Pivotal Point Amidst Funding and Trial Hurdles
Neuroscience & Brain Research

Parkinson’s Disease Research Reaches Pivotal Point Amidst Funding and Trial Hurdles

rifanmuazin Mar 14, 2026 0

The scientific understanding of Parkinson’s disease (PD) has advanced significantly, placing preclinical and clinical research at a critical juncture. However,…

Read More
Stem Cell & Regenerative Medicine

Michigan State University Researchers Identify Metabolic Molecular Switch in Sperm with Major Implications for Infertility and Male Contraception

rifanmuazin Mar 14, 2026 0

A team of biomedical researchers at Michigan State University (MSU) has announced the identification of a critical molecular "switch" that…

Read More
Doherty Institute researchers unveil an assay that identifies four STIs and antibiotic resistance in under an hour with up to 100% precision.Molecular Switch FLI-1 Identified as Key Regulator for Blood Stem Cell Activation and Enhanced Regenerative Medicine OutcomesAustralia’s Miocene Rainforest Entombed in Iron: A Remarkable Fossil Discovery Rewrites Paleontological ParadigmsTWiV 1285: Encapsidating Viruses 2025
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ